Software Convergence Research Institute accelerates its push into the global market for AI non-invasive glucose meters

Sofrware Convergence Research Institute is accelerating global commercialization of its non-invasive glucose monitor, EDL Doctor, after completing China prototype exports and overseas product certifications.

It secured key approvals from Korea’s MFDS, the US FCC, Japan’s PSE, China’s SRRC, and India’s WPC, strengthening its entry into overseas markets.

The company also raised 700 million won in R&D funding and is setting up a Hong Kong base to speed up commercialization and develop additional medical devices.

With AI healthcare capabilities that measure glucose and metabolic health without blood draws, it is positioning for broader competition in digital health.